Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.

12026Background: Immune checkpoint inhibitor (ICI) therapy is now commonly used in a range of tumours and settings. Most data relating to outcomes and rates of immune-related adverse events (irAE) ...